SCHEMBL7744649

SCHEMBL7744649

O=C(Nc1oc(-c2ccccc2O)nc1-c1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.58
FLT1 P17948 1/20 0.58
FLT4 P35916 1/20 0.58
ABCG2 Q9UNQ0 2/20 0.48
CHUK O15111 1/20 0.46
CASP3 P42574 1/20 0.46
TXNRD1 Q16881 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
NOX4 Q9NPH5 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746598 0.89 KDR (0.58) KDRFLT1FLT4ABCG2ADORA1
SCHEMBL7982243 0.87 KDR (0.48) KDRFLT1FLT4ABCG2CHUK
SCHEMBL4737638 0.86 KDR (0.55) KDRFLT1FLT4ABCG2SMN1; SMN2
SCHEMBL7739009 0.86 KDR (0.77) KDRFLT1FLT4CHUKCASP3
SCHEMBL7746601 0.84 KDR (0.53) KDRFLT1FLT4ABCG2SMN1; SMN2
SCHEMBL7985537 0.84 KDR (0.53) KDRFLT1FLT4SMN1; SMN2HPGD
SCHEMBL7744086 0.82 KDR (0.51) KDRFLT1FLT4CHUKTXNRD1
SCHEMBL7746649 0.81 KDR (0.47) KDRFLT1FLT4ABCG2SMN1; SMN2
SCHEMBL7746566 0.81 FLT1 (0.49) KDRFLT1FLT4ABCG2SMN1; SMN2
SCHEMBL7744059 0.80 KDR (0.53) KDRFLT1FLT4KDM4EHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed